GGHCX
Price
$38.92
Change
+$0.16 (+0.41%)
Updated
Oct 8 closing price
Net Assets
1.22B
JFNIX
Price
$74.71
Change
+$0.48 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
Interact to see
Advertisement

GGHCX vs JFNIX

Header iconGGHCX vs JFNIX Comparison
Open Charts GGHCX vs JFNIXBanner chart's image
Invesco Health Care A
Price$38.92
Change+$0.16 (+0.41%)
VolumeN/A
Net Assets1.22B
Janus Henderson Global Life Sciences I
Price$74.71
Change+$0.48 (+0.65%)
VolumeN/A
Net Assets4.49B
GGHCX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
GGHCX vs. JFNIX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGHCX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.49B vs. GGHCX (1.22B). JFNIX pays higher dividends than GGHCX: JFNIX (0.38) vs GGHCX (0.00). GGHCX was incepted earlier than JFNIX: GGHCX (36 years) vs JFNIX (16 years). GGHCX (1.05) is less costly to investors than JFNIX (0.77). GGHCX is a more actively managed with annual turnover of: 56.00 vs. JFNIX (35.00). GGHCX has a lower initial minimum investment than JFNIX: GGHCX (1000) vs JFNIX (2500). GGHCX annual gain was more profitable for investors over the last year : -4.68 vs. JFNIX (-6.30). JFNIX return over 5 years is better than : 8.06 vs. GGHCX (-13.20).
GGHCXJFNIXGGHCX / JFNIX
Total Expense Ratio1.050.77136%
Annual Report Gross Expense Ratio1.050.77136%
Fund Existence36 years16 years-
Gain YTD9.7279.130107%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.22B4.49B27%
Annual Yield % from dividends0.000.38-
Returns for 1 year-4.68-6.3074%
Returns for 3 years21.7824.2990%
Returns for 5 years-13.208.06-164%
Returns for 10 years-7.8141.04-19%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEKAX22.55N/A
N/A
DWS Emerging Markets Equity A
TOLSX16.88N/A
N/A
DWS RREEF Global Infrastructure S
CHCZX13.66N/A
N/A
AB Discovery Growth Z
FCPAX35.41N/A
N/A
Fidelity Advisor Intl Capl App A
SPVYX23.75N/A
N/A
SEI Small Cap Value Y (SIMT)